TL;DR
Handgrip strength (HGS) is more than just a measure of "old man strength"—it is a dynamic biomarker for heart health. This study demonstrates that the trajectory of your grip strength over time is a significantly better predictor of cardiovascular disease (CVD) than a single baseline measurement, with particularly pronounced risks observed in East Asian populations.
What Problem Does This Paper Address?
Cardiovascular disease remains the leading cause of death globally, making early risk assessment vital. While handgrip strength has long been recognized as a simple, non-invasive proxy for muscle function and general aging, most clinical research treats it as a static "snapshot."
The authors argue that this approach ignores the reality of human biology: strength fluctuates. A single measurement cannot capture the "dynamic burden" of muscle loss or the potential benefits of strength gains over time. Furthermore, most existing HGS research focuses on single populations, leaving a gap in our understanding of how these strength-to-heart-health associations vary across different ethnicities and regions.
Methods
The researchers employed a longitudinal, cross-cohort approach to track how HGS changes over several years. They moved beyond simple baseline measurements by defining two key concepts:
- HGS Transitions: Categorizing participants based on how they moved between "Low," "Moderate," and "High" strength groups between their first and second check-ups (e.g., High $\rightarrow$ Low).
- HGS Burdens: They developed three continuous indicators to quantify the "dose" of strength exposure:
- HGS Slope: The rate of change over time.
- Cumulative HGS: The total "area under the curve" of strength over the follow-up period.
- Relative Cumulative HGS: The degree of change relative to the participant's starting point.
To test predictive power, they integrated these metrics into SCORE2, a standard clinical algorithm for predicting 10-year CVD risk, using machine learning models including XGBoost, LightGBM, and RandomForest.
Datasets
The study analyzed a massive dataset of 73,555 participants across four major international cohorts:
- UK Biobank (UKB): Representing White Europeans.
- Survey of Health, Ageing and Retirement in Europe (SHARE): A broader European aging cohort.
- China Health and Retirement Longitudinal Study (CHARLS): Representing East Asians.
- Korean Longitudinal Study of Ageing (KLOSA): Representing East Asians.
Key Insights and Ideas
- The Trajectory is the Message: A decline in HGS was a much stronger predictor of heart attack or stroke than simply having low HGS to begin with. Conversely, participants who increased their strength during follow-up saw a reduction in CVD risk, suggesting that muscle maintenance is a modifiable risk factor.
- Ethnic Sensitivity: The association between declining HGS and CVD was significantly more pronounced in East Asian cohorts (CHARLS and KLOSA) than in European ones. The authors hypothesize this may be due to differences in body composition, such as "sarcopenic obesity"—a phenotype where low muscle mass is combined with high visceral fat, which is more common in Asian populations and highly inflammatory.
- "Free" Predictive Gains: HGS is incredibly cheap and easy to measure. By adding these longitudinal HGS metrics to the standard SCORE2 model (which usually requires blood work and blood pressure), the researchers achieved a substantial boost in accuracy without needing expensive new clinical tests.
Key Results
- Incident Cases: Over the follow-up period, 4,722 (6.4%) participants developed CVD.
- Risk of Decline: Shifting from "High" to "Decreased" HGS was associated with a 31.2% elevated risk of CVD compared to those who stayed strong.
- The Power of Cumulative Strength: For every standard deviation decrease in cumulative HGS, the risk of CVD jumped by 44%.
- Model Improvement: Incorporating dynamic HGS metrics into risk models increased the Area Under the Curve (AUC)—a measure of predictive accuracy—by up to 7.6% in Europeans and 5.9% in East Asians.
Limitations and Future Work
The authors acknowledge several limitations:
- Residual Confounding: While they adjusted for many factors, they couldn't fully account for every medication or specific comorbidity that might influence both strength and heart health.
- Measurement Noise: HGS can be influenced by acute factors like temporary fatigue, minor hand injuries, or even the participant's mood on the day of the test.
- Definition Heterogeneity: CVD was defined via ICD codes in the UK Biobank but relied on self-reporting in other cohorts, which could introduce bias.
Future Work: The researchers suggest that future studies should investigate the specific biological mechanisms—such as chronic low-grade inflammation or mitochondrial dysfunction—that link muscle loss to vascular injury. They also call for clinical trials to see if strength-training interventions specifically targeted at HGS preservation can directly lower CVD incidence.
Summary updated